Listed drug companies to overcome slow sales with profitability.

According to the management analysis for the listed pharmaceutical companies of the fiscal year ended at Dec. 31, the total sales up to 3/4 of 2005 reported at 3,171,900 million won, which was 6.17% up from the previous year period of 2,820,500 million won.

Compared to the same period last year, the profitability profiles showed 10.5% up at 381,400 million won of the operating incomes, 24% ...